☰

Sanaz Khanbolooki, Ph.D. - Publications

Affiliations: 
2006 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Metwalli AR, Khanbolooki S, Jinesh G, Sundi D, Shah JB, Shrader M, Choi W, Lashinger LM, Chunduru S, McConkey DJ, McKinlay M, Kamat AM. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells. Cancer Biology & Therapy. 10: 885-92. PMID 20814238 DOI: 10.4161/Cbt.10.9.13237  0.444
2006 Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Molecular Cancer Therapeutics. 5: 2251-60. PMID 16985059 DOI: 10.1158/1535-7163.Mct-06-0075  0.707
2006 Pan X, Yamamoto T, Arumugam T, Ji B, Khanbolooki S, McConkey D, Logsdon CD. SILENCING OF RELA/P65 ENHANCES TRAIL BUT NOT GEMCITABINE MEDIATED APOPTOSIS IN PANCREATIC CANCER CELLS Pancreas. 33: 487-488. DOI: 10.1097/00006676-200611000-00173  0.537
2004 Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. Cancer Biology & Therapy. 3: 1217-24. PMID 15477758 DOI: 10.4161/Cbt.3.12.1221  0.56
Show low-probability matches.